It's a common condition involving hypertension with serious consequences when left untreated. A Dallas Ob-gyn explains why she thinks the test is a game-changer.

The common genetic heart condition under the lens is hypertrophic cardiomyopathy (HCM). The problem is that there is no cure ...

The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...

The MCED test shows similar performance in cancer survivors and the general population, with a PPV of 50% and high ...

Scientists develop new blood test to identify individuals at high risk of developing hypertrophic cardiomyopathy, most common ...

A new bipartisan bill would end the coverage gap for dementia screening, allowing early diagnosis when treatments are most ...

But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...

New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially ...

Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...

The anion gap blood test measures the acid-base and electrolyte balance in the blood. Results can show whether there is an imbalance in a person’s pH levels, which may be making the blood too acidic ...

Sri Jayadeva Institute of Cardiovascular Sciences and Research has installed an advanced blood test analyser, the Roche Cobas ...